Informations générales (source: ClinicalTrials.gov)
Hétérogénéité Des Tumeurs Rhabdoides : Approches en " Cellules Uniques " Pour Identifier Des Cibles thérapeutiques (InnovRT-2)
Observational
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
mars 2022
avril 2025
29 juin 2024
The aim is to describe at the cellular level the heterogeneity of rhabdoid tumors, and
identify how this diversity influences resistance to treatment.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP - Hôpital Necker-Enfants Malades | BOURDEAUT Franck | 12/04/2024 09:27:49 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CLCC INSTITUT CURIE | Franck BOURDEAUT, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Aged 0-17 years old
- having a rhabdoid tumor according to clinical and radiological features Or likely
having a rhabdoid tumor according to clinical and radiological features
- surgical resection in standard care
- sufficient material for both diagnosis and experimental procedures
- parents' agreement
- Aged 0-17 years old
- having a rhabdoid tumor according to clinical and radiological features Or likely
having a rhabdoid tumor according to clinical and radiological features
- surgical resection in standard care
- sufficient material for both diagnosis and experimental procedures
- parents' agreement